Published in Nat Med on November 06, 2011
Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28
Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med (2013) 2.74
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis (2013) 2.39
The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37
Immunology of age-related macular degeneration. Nat Rev Immunol (2013) 2.14
Characterization of the cartilage DNA methylome in knee and hip osteoarthritis. Arthritis Rheumatol (2014) 1.77
Complement in immune and inflammatory disorders: therapeutic interventions. J Immunol (2013) 1.64
NFATc1 and NFATc2 repress spontaneous osteoarthritis. Proc Natl Acad Sci U S A (2013) 1.61
Brief report: carboxypeptidase B serves as a protective mediator in osteoarthritis. Arthritis Rheumatol (2014) 1.46
Matrix cross-linking-mediated mechanotransduction promotes posttraumatic osteoarthritis. Proc Natl Acad Sci U S A (2015) 1.46
Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis (2013) 1.40
Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr Rheumatol Rep (2013) 1.31
Immunopathogenesis of osteoarthritis. Clin Immunol (2013) 1.29
Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis (2012) 1.23
Prognostic biomarkers in osteoarthritis. Curr Opin Rheumatol (2013) 1.18
Complement, a target for therapy in inflammatory and degenerative diseases. Nat Rev Drug Discov (2015) 1.16
Post-traumatic osteoarthritis: from mouse models to clinical trials. Nat Rev Rheumatol (2013) 1.15
Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol (2014) 1.15
How might contact with nature promote human health? Promising mechanisms and a possible central pathway. Front Psychol (2015) 1.03
Cartilage damage in osteoarthritis and rheumatoid arthritis-two unequal siblings. Nat Rev Rheumatol (2015) 1.03
Synovium and the innate inflammatory network in osteoarthritis progression. Curr Rheumatol Rep (2013) 1.03
The complotype: dictating risk for inflammation and infection. Trends Immunol (2012) 1.03
Disease progression and phasic changes in gene expression in a mouse model of osteoarthritis. PLoS One (2013) 1.02
New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis (2013) 1.00
Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum (2013) 1.00
The different roles of aggrecan interaction domains. J Histochem Cytochem (2012) 1.00
Targets, models and challenges in osteoarthritis research. Dis Model Mech (2015) 0.99
Complement in the immunopathogenesis of rheumatic disease. Nat Rev Rheumatol (2012) 0.98
Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol (2015) 0.97
Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol Sci (2014) 0.96
MicroRNA-21 controls the development of osteoarthritis by targeting GDF-5 in chondrocytes. Exp Mol Med (2014) 0.95
The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol (2015) 0.92
Chondrocyte Apoptosis in the Pathogenesis of Osteoarthritis. Int J Mol Sci (2015) 0.91
A systems view of risk factors for knee osteoarthritis reveals insights into the pathogenesis of the disease. Ann Biomed Eng (2014) 0.89
Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin Proteomics (2014) 0.89
Future directions for the management of pain in osteoarthritis. Int J Clin Rheumtol (2014) 0.89
Inflammation in joint injury and post-traumatic osteoarthritis. Osteoarthritis Cartilage (2015) 0.87
Factors and mechanisms involved in the coupling from bone resorption to formation: how osteoclasts talk to osteoblasts. J Bone Metab (2014) 0.86
Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Auto Immun Highlights (2012) 0.86
Zone-specific gene expression patterns in articular cartilage. Arthritis Rheum (2013) 0.86
Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. Osteoarthritis Cartilage (2015) 0.84
Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol (2016) 0.84
Inflammatory biomarkers in osteoarthritis. Osteoarthritis Cartilage (2015) 0.84
High affinity humanized antibodies without making hybridomas; immunization paired with mammalian cell display and in vitro somatic hypermutation. PLoS One (2012) 0.83
Recognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis. J Immunol Res (2015) 0.83
Does lipopolysaccharide-mediated inflammation have a role in OA? Nat Rev Rheumatol (2015) 0.83
The growing array of innate inflammatory ignition switches in osteoarthritis. Arthritis Rheum (2012) 0.83
A gene expression study of normal and damaged cartilage in anteromedial gonarthrosis, a phenotype of osteoarthritis. Osteoarthritis Cartilage (2013) 0.82
Integrative meta-analysis of differentially expressed genes in osteoarthritis using microarray technology. Mol Med Rep (2015) 0.82
Unicompartmental and bicompartmental knee osteoarthritis show different patterns of mononuclear cell infiltration and cytokine release in the affected joints. Clin Exp Immunol (2015) 0.82
Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint. Tissue Eng Part B Rev (2014) 0.81
Chondroitin sulphate: a focus on osteoarthritis. Glycoconj J (2016) 0.81
Metabolic enrichment of omega-3 polyunsaturated fatty acids does not reduce the onset of idiopathic knee osteoarthritis in mice. Osteoarthritis Cartilage (2014) 0.81
Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties. Arthritis Res Ther (2012) 0.81
Proteomic profiling and functional characterization of early and late shoulder osteoarthritis. Arthritis Res Ther (2013) 0.81
Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity. Arthritis Rheumatol (2017) 0.81
Biomarkers of (osteo)arthritis. Biomarkers (2015) 0.81
A high-throughput model of post-traumatic osteoarthritis using engineered cartilage tissue analogs. Osteoarthritis Cartilage (2014) 0.81
Republished: Value of biomarkers in osteoarthritis: current status and perspectives. Postgrad Med J (2014) 0.80
Establishment of a surgically-induced model in mice to investigate the protective role of progranulin in osteoarthritis. J Vis Exp (2014) 0.80
Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res (2017) 0.80
Pain, motor and gait assessment of murine osteoarthritis in a cruciate ligament transection model. Osteoarthritis Cartilage (2013) 0.79
Exploring the cellular basis of human disease through a large-scale mapping of deleterious genes to cell types. Genome Med (2015) 0.78
Oral and topical boswellic acid attenuates mouse osteoarthritis. Osteoarthritis Cartilage (2013) 0.78
A computational method to differentiate normal individuals, osteoarthritis and rheumatoid arthritis patients using serum biomarkers. J R Soc Interface (2014) 0.78
MicroRNA-9 regulates the development of knee osteoarthritis through the NF-kappaB1 pathway in chondrocytes. Medicine (Baltimore) (2016) 0.78
Sequential depletion of human serum for the search of osteoarthritis biomarkers. Proteome Sci (2012) 0.78
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis. Biomarkers (2013) 0.78
Gla-rich protein, a new player in tissue calcification? Adv Nutr (2012) 0.78
MALDI-TOF-MS serum protein profiling for developing diagnostic models and identifying serum markers for discogenic low back pain. BMC Musculoskelet Disord (2014) 0.78
Decreased expression of microRNA-130a correlates with TNF-α in the development of osteoarthritis. Int J Clin Exp Pathol (2015) 0.78
The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis. Mol Ther (2016) 0.77
Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis. Arthritis Res Ther (2015) 0.77
The C-type lectin of the aggrecan G3 domain activates complement. PLoS One (2013) 0.77
Anti-complement activity of the Ixodes scapularis salivary protein Salp20. Mol Immunol (2015) 0.77
The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1. J Neurosci (2016) 0.77
The Role of miRNAs in Common Inflammatory Arthropathies: Osteoarthritis and Gouty Arthritis. Biomolecules (2016) 0.77
Transglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis. Amino Acids (2016) 0.76
Renoprotective Mechanism of Remote Ischemic Preconditioning Based on Transcriptomic Analysis in a Porcine Renal Ischemia Reperfusion Injury Model. PLoS One (2015) 0.76
Complement activation and expression during chronic relapsing experimental autoimmune encephalomyelitis in the Biozzi ABH mouse. Clin Exp Immunol (2015) 0.76
Plasma proteins take their toll on the joint in osteoarthritis. Arthritis Res Ther (2012) 0.76
Osteoarthritis: Complement-mediated inflammation in OA progression. Nat Rev Rheumatol (2011) 0.76
Innate immunity sensors participating in pathophysiology of joint diseases: a brief overview. J Long Term Eff Med Implants (2014) 0.76
Preparation of Low Molecular Weight Chondroitin Sulfates, Screening of a High Anti-Complement Capacity of Low Molecular Weight Chondroitin Sulfate and Its Biological Activity Studies in Attenuating Osteoarthritis. Int J Mol Sci (2016) 0.75
Comparative study of serum proteomes in Legg-Calve-Perthes disease. BMC Musculoskelet Disord (2015) 0.75
Exercise-driven metabolic pathways in healthy cartilage. Osteoarthritis Cartilage (2016) 0.75
Cell Death in Chondrocytes, Osteoblasts, and Osteocytes. Int J Mol Sci (2016) 0.75
Macroscopical, Histological, and In Vitro Characterization of Nonosteoarthritic Versus Osteoarthritic Hip Joint Cartilage. Clin Med Insights Arthritis Musculoskelet Disord (2016) 0.75
Sex-Specific Protection of Osteoarthritis by Deleting Cartilage Acid Protein 1. PLoS One (2016) 0.75
Genetic determinism of bone and mineral metabolism in meat-type chickens: A QTL mapping study. Bone Rep (2016) 0.75
Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products. Evid Based Complement Alternat Med (2015) 0.75
Immune Mediators in Osteoarthritis: Infrapatellar Fat Pad-Infiltrating CD8+ T Cells Are Increased in Osteoarthritic Patients with Higher Clinical Radiographic Grading. Int J Rheumatol (2016) 0.75
Complement Membrane Attack and Tumorigenesis: A SYSTEMS BIOLOGY APPROACH. J Biol Chem (2016) 0.75
Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis. Arthritis Res Ther (2014) 0.75
The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. Arthritis Res Ther (2016) 0.75
Deletion of the membrane complement inhibitor CD59a drives age and gender-dependent alterations to bone phenotype in mice. Bone (2015) 0.75
Novel approaches for treating musculoskeletal diseases: molecular orthopedics and systems medicine. Open Orthop J (2013) 0.75
Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases. PLoS One (2016) 0.75
Effects of mechanical stress on chondrocyte phenotype and chondrocyte extracellular matrix expression. Sci Rep (2016) 0.75
Relationship between atherosclerosis and knee osteoarthritis as graded by radiography and ultrasonography in females. J Phys Ther Sci (2016) 0.75
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature (2005) 5.71
Osteoarthritis. J Cell Physiol (2007) 5.55
Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med (2006) 5.26
Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum (2001) 5.24
Clinical practice. Osteoarthritis of the knee. N Engl J Med (2006) 4.69
ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature (2005) 4.24
Risk factors for symptomatic knee osteoarthritis fifteen to twenty-two years after meniscectomy. Arthritis Rheum (2004) 2.96
Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1992) 2.84
Modulating hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med (2009) 2.81
Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis. Ann Rheum Dis (2007) 2.81
Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45
Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage (2005) 2.36
T-cell regulation: with complements from innate immunity. Nat Rev Immunol (2006) 2.27
Genetic control of resistance to Listeria monocytogenes: regulation of leukocyte inflammatory responses by the Hc locus. J Immunol (1984) 2.19
High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther (2007) 1.88
Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum (2011) 1.74
Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol (1997) 1.73
Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood (2001) 1.65
Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? Curr Opin Rheumatol (2008) 1.64
The extracellular matrix and inflammation: fibromodulin activates the classical pathway of complement by directly binding C1q. J Biol Chem (2005) 1.61
Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol (2008) 1.45
Generation of a monoclonal antibody to mouse C5 application in an ELISA assay for detection of anti-C5 antibodies. Mol Cell Probes (1987) 1.37
In vivo osteoarthritis target validation utilizing genetically-modified mice. Curr Drug Targets (2007) 1.34
The CatWalk method: a detailed analysis of behavioral changes after acute inflammatory pain in the rat. J Neurosci Methods (2007) 1.30
Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum (2010) 1.23
Cell signals transduced by complement. Mol Immunol (2004) 1.21
Genetics. Was the Human Genome Project worth the effort? Science (2005) 1.16
Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol (2009) 1.13
Sublytic complement attack induces cell cycle in oligodendrocytes. J Immunol (1996) 1.10
Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice. J Immunol (2009) 1.09
Protein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos induction. J Biol Chem (2010) 1.08
Mechanisms of effects of complement inhibition in murine collagen-induced arthritis. Arthritis Rheum (2002) 1.02
Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol (1993) 1.00
Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther (2008) 1.00
Terminal complement complex C5b-9-treated human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization. Eur J Immunol (2007) 0.98
The deposition of immunoglobulins and complement in osteoarthritic cartilage. Int Orthop (1980) 0.98
Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis. Clin Exp Immunol (2001) 0.95
Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes. J Neuroimmunol (2003) 0.87
Significance of immune complex deposits in osteoarthritic cartilage. J Rheumatol (1987) 0.86
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat Genet (2007) 8.74
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8.33
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 7.86
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med (2007) 6.80
The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature (2011) 6.71
Osteoarthritis. J Cell Physiol (2007) 5.55
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum (2005) 4.84
Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum (2012) 4.28
Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 4.22
The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest (2008) 4.09
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination. Nature (2007) 3.92
Immune activation in brain aging and neurodegeneration: too much or too little? Neuron (2009) 3.76
Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest (2006) 3.51
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature (2008) 3.48
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet (2009) 3.36
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum (2006) 3.33
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol (2002) 3.20
Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis Rheum (2004) 3.06
New approaches to the treatment of dense deposit disease. J Am Soc Nephrol (2007) 3.02
Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis. Int J Radiat Oncol Biol Phys (2006) 2.94
C3 glomerulopathy: consensus report. Kidney Int (2013) 2.85
Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci (2009) 2.82
Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum (2011) 2.74
Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci (2010) 2.73
Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med (2006) 2.68
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein. Nat Med (2007) 2.64
Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum (2008) 2.62
The central role of the alternative complement pathway in human disease. J Immunol (2006) 2.53
Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis. Sci Transl Med (2013) 2.51
Degos disease: a C5b-9/interferon-α-mediated endotheliopathy syndrome. Am J Clin Pathol (2011) 2.50
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50
The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells. Arthritis Res Ther (2011) 2.48
Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial. J Rheumatol (2011) 2.45
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science (2005) 2.41
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest (2003) 2.39
Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis (2013) 2.39
Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol (2009) 2.39
Complement activation fragment Bb in early pregnancy and spontaneous preterm birth. Am J Obstet Gynecol (2008) 2.38
Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat Immunol (2009) 2.37
The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37
Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med (2003) 2.35
Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum (2009) 2.33
Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med (2005) 2.31
Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum (2005) 2.30
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci U S A (2003) 2.24
Neutrophil-derived leukotriene B4 is required for inflammatory arthritis. J Exp Med (2006) 2.21
Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis. Kidney Int (2011) 2.20
N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis. J Immunol (2011) 2.18
Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One (2012) 2.18
Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med (2008) 2.17
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J Exp Med (2008) 2.17
Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med (2006) 2.16
Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis. Arthritis Rheumatol (2014) 2.14
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum (2008) 2.13
Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat Immunol (2006) 2.12
Classical MHCI molecules regulate retinogeniculate refinement and limit ocular dominance plasticity. Neuron (2009) 2.11
Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor. Arthritis Rheum (2011) 2.11
Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. J Clin Invest (2006) 2.10
Rheumatic diseases: the effects of inflammation on bone. Immunol Rev (2005) 2.07
Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J Neurosci (2004) 2.07
Autophagy in human health and disease. N Engl J Med (2013) 2.04
Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron (2003) 2.02
Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A (2007) 2.02
Structure of the Epstein-Barr virus major envelope glycoprotein. Nat Struct Mol Biol (2006) 2.01
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab (2010) 2.01
Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet (2009) 1.96
Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol (2008) 1.93
HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem (2007) 1.92
Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol (2003) 1.89
High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther (2007) 1.88
Acute renal failure after bilateral nephrectomy is associated with cytokine-mediated pulmonary injury. J Am Soc Nephrol (2006) 1.88
The arthroscopic Latarjet procedure for the treatment of anterior shoulder instability. Arthroscopy (2007) 1.87
Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest (2006) 1.87
The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum (2010) 1.86
Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. Arch Neurol (2007) 1.86
Cadherin-11 regulates fibroblast inflammation. Proc Natl Acad Sci U S A (2011) 1.85
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc Natl Acad Sci U S A (2007) 1.84
Gout: why is this curable disease so seldom cured? Ann Rheum Dis (2012) 1.84
Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 1.83
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases. Blood (2011) 1.82
CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol (2006) 1.81
Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine. Biomaterials (2012) 1.81
Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept. Arthritis Rheum (2007) 1.80